After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Caredx Inc is listed on the NASDAQ in the Healthcare sector while operating in the Diagnostics & Research industry. The current market capitalization of Caredx Inc is $629.14M. A total of 0.8 million shares were traded on the day, compared to an average of 1.53M shares.
In the most recent transaction, Novack Jeffrey Adam sold 2,688 shares of CDNA for 12.79 per share on Aug 05 ’25. After the transaction, the Secretary and General Counsel now owns 112,930 company shares. In a previous transaction on Aug 05 ’25, Jeffrey Adam Novack bought 2,688 shares at 12.60 per share.
Among the insiders who sold shares, Maag Peter disposed of 10,000 shares on Jul 07 ’25 at a per-share price of $18.58. This resulted in the Director holding 308,846 shares of CDNA after the transaction. In another insider transaction, Valantine Hannah sold 10,570 shares at $19.16 per share on Jun 18 ’25. Company shares held by the Director now total 38,994.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, CDNA has a high of $34.84 and a low of $10.96.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. CDNA’s latest balance sheet shows that the firm has $348.49M in Cash & Short Term Investments as of fiscal 2021. There were $21.35M in debt and $77.30M in liabilities at the time. Its Book Value Per Share was $6.15, while its Total Shareholder’s Equity was $465.88M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CDNA is Buy with a score of 4.25.
